Neumora Therapeutics, Inc. (NMRA)
(Delayed Data from NSDQ)
$11.55 USD
+0.79 (7.34%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $11.57 +0.02 (0.17%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 2.86% |
ABR | 1.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.46 |
Next Year | -1.54 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.39 | -1.46 | -1.54 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.35 | -0.37 | -1.43 | -1.57 |
High Estimate | -0.34 | -0.35 | -1.37 | -1.42 |
Low Estimate | -0.41 | -0.44 | -1.64 | -1.75 |
Year ago EPS | NA | -1.14 | -3.63 | -1.46 |
Year over Year Growth Est. | NA | 65.79% | 59.78% | -5.31% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.39 | -1.46 | -1.54 |
7 Days Ago | -0.37 | -0.39 | -1.46 | -1.54 |
30 Days Ago | -0.37 | -0.39 | -1.46 | -1.54 |
60 Days Ago | -0.37 | -0.39 | -1.47 | -1.54 |
90 Days Ago | -0.37 | -0.39 | -1.48 | -1.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.39 | -1.41 | -1.42 |
Zacks Consensus Estimate | -0.37 | -0.39 | -1.46 | -1.54 |
Earnings ESP | 0.00% | 0.00% | 3.59% | 7.79% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.71 | -1.14 | NA | NA |
Estimate | -0.35 | -0.65 | -0.48 | NA | NA |
Difference | 0.01 | -0.06 | -0.66 | NA | -0.24 |
Surprise | 2.86% | -9.23% | -137.50% | NA | -47.96% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more